Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study
Dr Deverick J Anderson, MD, Dr Deverick J Anderson, Dr Deverick J Anderson, Luke F Chen, MBBS, Prof David J Weber, MD, Rebekah W Moehring, MD, Sarah S Lewis, MD, Patricia F Triplett, MD, Michael Blocker, MD, Paul Becherer, MD, J Conrad Schwab, MD, Lauren P Knelson, MSPH, Yuliya Lokhnygina, PhD, William A Rutala, PhD, Hajime Kanamori, MD, Maria F Gergen, MT ASCP, Prof Daniel J Sexton, MD for the CDC Prevention Epicenters Program The Lancet